About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multiple Sclerosis Clinical Trials in New York | 57 Studies

Clinical Trials Multiple SclerosisNew York

Multiple Sclerosis Clinical Trials in New York

Find 57 clinical trials for multiple sclerosis near New York, New York. Connect with research centers in your area.

All Multiple Sclerosis trials nationwide All trials in New York

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 57 trials

CompletedStudy to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With AvonexThe primary objective of the study is to evaluate the efficacy of BIIB033 in participants with active relapsing multiple sclerosis (MS) when used concurrently with Avonex.NCT01864148·Cullman, Alabama and 71 others

Multiple Sclerosis Trials in Other Cities

Los Angeles Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedIntrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple SclerosisThis is a phase II, double-blinded, placebo-controlled, randomized, cross-over Study designed to determine the efficacy of multiple intrathecal administrations of autologous…NCT03355365·New York, New York

CompletedA Study of Suboptimally Controlled Participants Previously Taking Oral or Infusion DMDs for RMS (MASTER-2)To evaluate the effectiveness, safety and Patient-Reported Outcomes (PROs) of cladribine tablets in participants with RMS including relapsing-remitting multiple sclerosis (RRMS)…NCT03933202·Cullman, Alabama and 65 others

UnknownOptic Neuritis Treatment Trial (ONTT)To assess the beneficial and adverse effects of corticosteroid treatment for optic neuritis. To determine the natural history of vision in patients who suffer optic neuritis.NCT00000146·Little Rock, Arkansas and 14 others

Active not recruitingA Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple SclerosisThis study is a prospective, multicenter, open-label, single-arm effectiveness and safety study in participants with progressive multiple sclerosis (PMS).NCT03523858·Laguna Hills, California and 119 others

CompletedSafety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple SclerosisThe purpose of this study is to determine if natalizumab in combination with AVONEX is safe and effective in delaying progression of individuals diagnosed with relapsing remitting…NCT00030966·Birmingham, Alabama and 87 others

CompletedEfficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple SclerosisTo determine if treatment with BG00012 can decrease the number of MS relapses during a certain time period.NCT00451451·Birmingham, Alabama and 194 others

CompletedEnvironmental and Genetic Risk Factors for Pediatric Multiple SclerosisThe purpose of this study is to better understand multiple sclerosis (MS) in children and adolescents, to learn if it differs from adult MS and to investigate if genes or…NCT01396343·Birmingham, Alabama and 16 others

CompletedA Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple SclerosisThis is a phase II, multicenter, randomized, parallel-group, partially blinded, placebo and Avonex (interferon beta-1a) controlled dose finding study to evaluate the efficacy as…NCT00676715·Phoenix, Arizona and 83 others

CompletedStudy of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple SclerosisThe purpose of this study is to determine whether Tcelna (imilecleucel-T, autologous T-Cell Immunotherapy) is effective in the treatment of secondary progressive multiple…NCT01684761·Phoenix, Arizona and 35 others

CompletedEfficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple SclerosisThis study assessed the safety, tolerability and efficacy of two doses of oral fingolimod compared to placebo on efficacy parameters in patients with relapsing-remitting multiple…NCT00355134·Birmingham, Alabama and 111 others

TerminatedA Study To Evaluate The Safety And Tolerability Of PF-06342674 (RN168) In Subjects With Multiple Sclerosis (MS)PF-06342674 (RN168), being developed for the treatment of multiple sclerosis (MS), is an antibody that binds to and inhibits the human interleukin-7 receptor, a component…NCT02045732·Albany, New York and 7 others

TerminatedDysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1The purpose of this study is to provide confirmatory evidence of the safety and efficacy of two Dysport® (AbobotulinumtoxinA) doses (600 units \[U\] and 800 U), compared to…NCT02660138·Birmingham, Alabama and 80 others

RecruitingEffect of Cooling on Balance Performance in Multiple SclerosisThe goal of this observational study to examine the effects of cooling on balance in persons with Multiple Sclerosis.NCT06094855·New York, New York

CompletedA Study to Analyze the Effect of Acupuncture on Mobility And Quality of Life in Multiple SclerosisThe purpose of this two-center study is to examine the effectiveness of acupuncture treatments in addressing mobility deficits, sensorimotor impairment, and quality of life (QOL)…NCT03174379·New York, New York

Enrolling by invitationElectromagnetic Immunotherapy Mapping and Cytokine Forecasting Study (QSIT)The ImmuneNet study is a Phase I/II clinical trial sponsored by Truway Health, Inc. It will test whether gentle, low-frequency electromagnetic resonance (LF-EMR) can influence how…NCT07221565·New York, New York

CompletedVirtual Reality (VR) to Improve Quality of Life in Patients Diagnosed With Neurological DisordersParticipants with neurological disorders will be recruited to complete sessions of virtual reality (VR) immersion.NCT03606668·New York, New York

TerminatedEffect of MD1003 in Progressive Multiple Sclerosis (SPI2)The purpose of this study is to demonstrate the superiority of MD1003 over placebo in the disability of patients suffering from progressive multiple sclerosis and especially those…NCT02936037·Phoenix, Arizona and 91 others

TerminatedLinking Cognitive Functioning to Multimodal Imaging in Multiple Sclerosis (MS)Multiple sclerosis (MS) is the most common progressive neurologic disorder to occur in adults of working-age.NCT03723356·New York, New York

CompletedpH-weighted MRI in Multiple Sclerosis: A Surrogate Marker of Tissue Metabolic StressTwenty subjects (10 patients and 10 age-matched control volunteers) will be recruited for this study.NCT03028675·New York, New York

PreviousPage 2 of 3Next

Other Conditions in New York

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia